Daniel Janse
Direktor/Vorstandsmitglied bei Triumvira Immunologics USA, Inc.
Aktive Positionen von Daniel Janse
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Triumvira Immunologics USA, Inc.
Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Direktor/Vorstandsmitglied | - | - |
EnPlusOne Biosciences, Inc
EnPlusOne Biosciences, Inc Packaged SoftwareTechnology Services EnPlusOne Biosciences, Inc is a company that develops an enzymatic synthesis platform to unlock site-specific and diverse RNA modification. The company is based in Watertown, MA. The company was founded by Dan Ahlstedt, George Church, Howon Lee, Daniel Wiegand, Jonathan Rittichier. Daniel Wiegand has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - | - |
Isolere Bio, Inc.
Isolere Bio, Inc. Pharmaceuticals: MajorHealth Technology Part of Donaldson Co., Inc., Isolere Bio, Inc. is an early-stage biotechnology company that develops novel and proprietary reagents. The company is based in Durham, NC. The company was founded in 2017 by Kelli Luginbuhl, Joseph McMahon, Ashutosh Chilkoti. Kelli Luginbuhl has been the CEO since 2017. Isolere Bio was acquired by Donaldson Co., Inc. on February 21, 2023 for $62.50 million. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Daniel Janse
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Director/Board Member | 3 |
Sektoral
Commercial Services | 2 |
Technology Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Triumvira Immunologics USA, Inc.
Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Commercial Services |
EnPlusOne Biosciences, Inc
EnPlusOne Biosciences, Inc Packaged SoftwareTechnology Services EnPlusOne Biosciences, Inc is a company that develops an enzymatic synthesis platform to unlock site-specific and diverse RNA modification. The company is based in Watertown, MA. The company was founded by Dan Ahlstedt, George Church, Howon Lee, Daniel Wiegand, Jonathan Rittichier. Daniel Wiegand has been the CEO since incorporation. | Technology Services |
Isolere Bio, Inc.
Isolere Bio, Inc. Pharmaceuticals: MajorHealth Technology Part of Donaldson Co., Inc., Isolere Bio, Inc. is an early-stage biotechnology company that develops novel and proprietary reagents. The company is based in Durham, NC. The company was founded in 2017 by Kelli Luginbuhl, Joseph McMahon, Ashutosh Chilkoti. Kelli Luginbuhl has been the CEO since 2017. Isolere Bio was acquired by Donaldson Co., Inc. on February 21, 2023 for $62.50 million. | Health Technology |
- Börse
- Insiders
- Daniel Janse
- Erfahrung